Antibacterial and Anti-biofilm Effect of Lactuca serriola Extract Against Clinically Isolated Porphyromonas gingivalis and Prevotella intermedia: An in vitro study [PDF]
Sulaimani Dental Journal, 2022 Objective: To investigate the antibacterial and anti-biofilm effect of Lactuca serriola (LS) extract against clinically isolated Porphyromonas gingivalis (P. gingivalis) and Prevotella intermedia (P. intermedia).
Rozhgar Sharif, Aram Mohammed Sha
doaj +3 more sources
Occurrence of prevotella nigrescens and prevotella intermedia in infections of endodontic origin
Journal of Endodontics, 1997 The occurrence of Prevotella intermedia and Prevotella nigrescens in endodontic infections was studied using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) of whole cell protein to distinguish between the species.
Bae, Kwang-Shik +3 more
core +3 more sources
Direct quantitative differentiation between Prevotella intermedia and Prevotella nigrescens in clinical specimens. [PDF]
Microbiology, 2002 This paper describes a quantitative fluorescent in situ hybridization (FISH) assay for the differential identification of Prevotella intermedia and Prevotella nigrescens in clinical samples, and compares its performance with less discriminatory culture ...
Thurnheer, T +3 more
core +5 more sources
Prevotella intermedia and Prevotella nigrescens serotypes, ribotypes and binding characteristics.
FEMS Microbiology Letters, 1996 Type strains and 62 clinical isolates of Prevotella intermedia and Prevotella nigrescens were typed with the use of genomic DNA fingerprints and rRNA gene probes.
Dahlén, G G, Gmür, R, Johnson, J R
core +2 more sources
Antibacterial and Antibiofilm Profiles of Thymus vulgaris Essential Oil on Clinically Isolated Porphyromonas Gingivalis and Prevotella intermedia An In Vitro Study [PDF]
Sulaimani Dental Journal, 2022 Objective: To investigate the antibacterial and antibiofilm effect of the essential oil extracted from Thymus vulgaris (TV) against clinically isolated Porphyromonas gingivalis (P. gingivalis) and Prevotella intermedia (P. intermedia).
Ayub Rasheed, Sarhang Gul, Hoshyar Azeez
doaj +3 more sources
Evaluation of 5-Aminolevulinic acid, Methylene Blue, Toluidine Blue O Photosensitizers on Clinically Isolated Porphyromonas gingivalis and Prevotella intermedia An in vitro Study [PDF]
Sulaimani Dental Journal, 2022 Objective: To evaluate the antibacterial efficacy of 5-aminolevulinic acid (5-ALA), methylene blue (MB), and toluidine blue O (TBO) photosensitizers against clinically isolated Porphyromonas gingivalis (P.
Kashan Najm, Sarhang Gul
doaj +3 more sources
Prevotella Intermedia Aggravates Subclinical Hypothyroidism
International Dental JournalAim or purpose: To verify the pathogenicity of P. intermedia in SCH, and preliminarily explore the possible mechanism. Materials and methods: The SCH mouse model with oral application of P.
Dong Ting, Fang Bing
doaj +2 more sources
Spondylodiscitis caused by Prevotella intermedia: A case report and literature review
Interdisciplinary Neurosurgery, 2017 Background: Spondylodiscitis is commonly caused by Staphylococcus aureus. Anaerobic organisms are the causative agents in only 3–4% of cases. Diagnosis of anaerobic spondylodiscitis can be challenging due to their low virulence nature.
Michael Opoku-Darko, W. Bradley Jacobs
doaj +2 more sources
Infected pericardial effusion caused by Prevotella intermedia: a rare diagnosis [PDF]
Frontiers in Cellular and Infection MicrobiologyPrevotella intermedia is a Gram-negative bacterium that thrives in anaerobic environments. It presents challenges in detection through routine laboratory assays, and hitherto, there has been no documented instance of detecting this bacterium in ...
Wan Xu +3 more
doaj +2 more sources
Anaerobe, 2000 This study compared the potential of three techniques to differentiate between the species Prevotella intermedia (ATCC 25611) and Prevotella nigrescens (ATCC 33563, ATCC 25261) including recent clinical isolates identified only as P.
Drucker, David +4 more
core +2 more sources